ACADIA HEALTHCARE CO INC (ACHC) Stock Fundamental Analysis
NASDAQ:ACHC - Nasdaq - US00404A1097 - Common Stock - Currency: USD
ACHC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ACHC while its profitability can be described as average. ACHC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ACHC had positive earnings in the past year.
ACHC had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ACHC reported negative net income in multiple years.
Each year in the past 5 years ACHC had a positive operating cash flow.
1.2 Ratios
ACHC's Return On Assets of 3.05% is fine compared to the rest of the industry. ACHC outperforms 64.08% of its industry peers.
With a decent Return On Equity value of 6.17%, ACHC is doing good in the industry, outperforming 65.05% of the companies in the same industry.
The Return On Invested Capital of ACHC (6.43%) is better than 66.02% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACHC is in line with the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 6.17% | ||
| ROIC | 6.43% |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
1.3 Margins
Looking at the Profit Margin, with a value of 5.94%, ACHC belongs to the top of the industry, outperforming 82.52% of the companies in the same industry.
In the last couple of years the Profit Margin of ACHC has grown nicely.
ACHC's Operating Margin of 14.95% is amongst the best of the industry. ACHC outperforms 87.38% of its industry peers.
In the last couple of years the Operating Margin of ACHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.95% | ||
| PM (TTM) | 5.94% | ||
| GM | N/A |
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ACHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ACHC has more shares outstanding
The number of shares outstanding for ACHC has been increased compared to 5 years ago.
ACHC has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.27, we must say that ACHC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ACHC (1.27) is worse than 67.96% of its industry peers.
ACHC has a Debt/Equity ratio of 0.72. This is a neutral value indicating ACHC is somewhat dependend on debt financing.
ACHC's Debt to Equity ratio of 0.72 is in line compared to the rest of the industry. ACHC outperforms 48.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.27 |
ROIC/WACC0.76
WACC8.41%
2.3 Liquidity
A Current Ratio of 1.35 indicates that ACHC should not have too much problems paying its short term obligations.
ACHC has a Current ratio (1.35) which is comparable to the rest of the industry.
ACHC has a Quick Ratio of 1.34. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
ACHC has a Quick ratio (1.34) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
ACHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.75%.
Measured over the past years, ACHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.21% on average per year.
ACHC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.48%.
The Revenue has been growing by 9.45% on average over the past years. This is quite good.
EPS 1Y (TTM)-18.75%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-52.38%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%0.32%
3.2 Future
The Earnings Per Share is expected to grow by 5.66% on average over the next years.
Based on estimates for the next years, ACHC will show a quite strong growth in Revenue. The Revenue will grow by 8.46% on average per year.
EPS Next Y-18.29%
EPS Next 2Y-5.15%
EPS Next 3Y-0.97%
EPS Next 5Y5.66%
Revenue Next Year5.52%
Revenue Next 2Y7.03%
Revenue Next 3Y7.15%
Revenue Next 5Y8.46%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.66, the valuation of ACHC can be described as very cheap.
Based on the Price/Earnings ratio, ACHC is valued cheaply inside the industry as 95.15% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.50. ACHC is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 7.38 indicates a rather cheap valuation of ACHC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACHC indicates a rather cheap valuation: ACHC is cheaper than 93.20% of the companies listed in the same industry.
ACHC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.66 | ||
| Fwd PE | 7.38 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ACHC is valued cheaper than 85.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.53 |
4.3 Compensation for Growth
ACHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.75
EPS Next 2Y-5.15%
EPS Next 3Y-0.97%
5. Dividend
5.1 Amount
ACHC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
21.92
-0.85 (-3.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners110.43%
Inst Owner Change-0.12%
Ins Owners1.39%
Ins Owner Change8.3%
Market Cap2.02B
Analysts82
Price Target42.69 (94.75%)
Short Float %12.22%
Short Ratio5.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.13%
Min EPS beat(2)-12.21%
Max EPS beat(2)9.95%
EPS beat(4)2
Avg EPS beat(4)-0.27%
Min EPS beat(4)-12.21%
Max EPS beat(4)9.95%
EPS beat(8)6
Avg EPS beat(8)1.47%
EPS beat(12)9
Avg EPS beat(12)9.78%
EPS beat(16)11
Avg EPS beat(16)7.83%
Revenue beat(2)0
Avg Revenue beat(2)-2.22%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.51%
Revenue beat(8)3
Avg Revenue beat(8)-1.06%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)5
Avg Revenue beat(16)-0.8%
PT rev (1m)-2.33%
PT rev (3m)-11.81%
EPS NQ rev (1m)1.48%
EPS NQ rev (3m)-7.59%
EPS NY rev (1m)0.55%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)-0.54%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.66 | ||
| Fwd PE | 7.38 | ||
| P/S | 0.64 | ||
| P/FCF | N/A | ||
| P/OCF | 4.37 | ||
| P/B | 0.66 | ||
| P/tB | 2.94 | ||
| EV/EBITDA | 6.53 |
EPS(TTM)2.86
EY13.05%
EPS(NY)2.97
Fwd EY13.54%
FCF(TTM)-2.82
FCFYN/A
OCF(TTM)5.02
OCFY22.9%
SpS34.26
BVpS33.02
TBVpS7.45
PEG (NY)N/A
PEG (5Y)0.75
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 6.17% | ||
| ROCE | 8.32% | ||
| ROIC | 6.43% | ||
| ROICexc | 6.54% | ||
| ROICexgc | 11.31% | ||
| OM | 14.95% | ||
| PM (TTM) | 5.94% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
ROICexc(3y)8.08%
ROICexc(5y)7.37%
ROICexgc(3y)16.06%
ROICexgc(5y)14.72%
ROCE(3y)10.25%
ROCE(5y)9.25%
ROICexcg growth 3Y-4.56%
ROICexcg growth 5Y16.02%
ROICexc growth 3Y1.65%
ROICexc growth 5Y14.56%
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.46 | ||
| Cap/Depr | 450.84% | ||
| Cap/Sales | 22.89% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 73.16% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | 1.27 |
F-Score6
WACC8.41%
ROIC/WACC0.76
Cap/Depr(3y)344.44%
Cap/Depr(5y)299.77%
Cap/Sales(3y)15.9%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.75%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-52.38%
EPS Next Y-18.29%
EPS Next 2Y-5.15%
EPS Next 3Y-0.97%
EPS Next 5Y5.66%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%0.32%
Revenue Next Year5.52%
Revenue Next 2Y7.03%
Revenue Next 3Y7.15%
Revenue Next 5Y8.46%
EBIT growth 1Y-9.84%
EBIT growth 3Y9.61%
EBIT growth 5Y10.7%
EBIT Next Year22.45%
EBIT Next 3Y13.59%
EBIT Next 5Y11.46%
FCF growth 1Y-820.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.81%
OCF growth 3Y-29.78%
OCF growth 5Y-15.9%